Ebert S N, Subramanian D, Shtrom S S, Chung I K, Parris D S, Muller M T
Department of Molecular Genetics, Ohio State University, Columbus 43210.
J Virol. 1994 Feb;68(2):1010-20. doi: 10.1128/JVI.68.2.1010-1020.1994.
Endogenous host topoisomerase II acts upon herpes simplex virus type 1 (HSV-1) DNA in infected cells (S.N. Ebert, S.S. Shtrom, and M.T. Muller, J. Virol. 56:4059-4066, 1990), and cleavage is directed exclusively at progeny viral DNA while parental DNA is resistant. To evaluate the possibility that HSV-1 induces topoisomerase II activity which could account for the preferential cleavage of progeny viral DNA, we assessed topoisomerase II cleavage activity on cellular and viral DNA substrates before and after the initiation of viral DNA replication. We show that cleavage of a host gene in mock-infected cells was similar to that observed in HSV-1-infected cells, regardless of whether viral DNA replication had occurred. In addition, quantitative measurements revealed comparable amounts of topoisomerase II activity in infected and mock-infected cells; thus, HSV-1 neither induces nor encodes its own type II topoisomerase and cleavages in vivo are due to a preexisting host topoisomerase. Human cells contain two isozymes of topoisomerase II (p170 and p180), encoded by separate genes. Through the use of isozyme-specific antibodies, we demonstrate that only p170 was found to be cross-linked to HSV-1 DNA even though both forms were present at nearly constant levels in HSV-1-infected cells. Immunofluorescence revealed that by 6 h postinfection, p170 becomes redistributed and localized to sites of active viral DNA synthesis. The data suggest that p170 gains preferential access to replicated viral DNA molecules, which explains why topoisomerase II activity is concentrated on progeny DNA.
内源性宿主拓扑异构酶II作用于感染细胞中的单纯疱疹病毒1型(HSV-1)DNA(S.N.埃伯特、S.S.什特罗姆和M.T.米勒,《病毒学杂志》56:4059 - 4066,1990年),切割仅针对子代病毒DNA,而亲代DNA具有抗性。为了评估HSV-1诱导拓扑异构酶II活性从而导致子代病毒DNA优先切割的可能性,我们在病毒DNA复制开始之前和之后评估了拓扑异构酶II对细胞和病毒DNA底物的切割活性。我们发现,无论病毒DNA复制是否发生,在 mock感染细胞中宿主基因的切割与在HSV-1感染细胞中观察到的相似。此外,定量测量显示感染细胞和mock感染细胞中拓扑异构酶II活性的量相当;因此,HSV-1既不诱导也不编码其自身的II型拓扑异构酶,体内的切割是由于预先存在的宿主拓扑异构酶。人类细胞含有由不同基因编码的两种拓扑异构酶II同工酶(p170和p180)。通过使用同工酶特异性抗体,我们证明即使在HSV-1感染细胞中两种形式的拓扑异构酶II几乎都以恒定水平存在,但只有p170被发现与HSV-1 DNA交联。免疫荧光显示,感染后6小时,p170重新分布并定位于活跃的病毒DNA合成位点。数据表明p170优先接触复制的病毒DNA分子,这解释了为什么拓扑异构酶II活性集中在子代DNA上。